RSP Stock UPDATES S&P 500 Index Equal Weight Guggenheim (RSP)

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
S&P 500 Index Equal Weight Guggenheim (RSP) 76.83 $RSP

An ETF Strategy for a Volatile Second Quarter
at The Street - Mon Mar 24, 10:28AM CDT
Selecting the right exchange-traded funds will help the investor play defense in this environment.

Investment Strategies 2014: How to Invest in Any Market
Jason Hall, The Motley Fool - Motley Fool - Sun Jan 12, 9:04AM CST
For investors, 2013 was one of the best years in recent memory. The S&P 500 climbed 29.6%, its best year since 1997, while the Dow Jones Industrial Average climbed just under 30% for its largest one-year jump since 1995.  Even the Nasdaq ...

This Tweaked Index Fund Has Been Trouncing the S&P 500
Selena Maranjian, The Motley Fool - Motley Fool - Mon Aug 12, 8:38PM CDT
Exchange-traded funds offer a convenient way to invest in sectors or niches that interest you. If you'd like to add some large-cap stocks to your portfolio but don't have the time or expertise to hand-pick a few, the Guggenheim S&P 500 Equal...

VelocityShares Launches Equal Risk Weighted ETF - ETF News And Commentary
Eric Dutram - Zacks Investment Research - Thu Aug 01, 9:15AM CDT
For an equal risk approach to large caps, take a look at this new fund from VelocityShares (ERW).

Overweight These Equal Weight ETFs in Your Portfolio - ETF News And Commentary
Zacks Equity Research - Zacks Investment Research - Mon Jul 29, 10:30AM CDT
Why investors might want to consider equal weight ETFs.

I Bet You're Probably Losing: Try Something That Actually Works
Blogs @ The Motley Fool - Motley Fool - Thu Jul 11, 2:50PM CDT
I read two articles today, that were both stark reminders that most of us are really bad at investing. From Foolish contributor Morgan Housel: Most investors underperform the market. When that's the case, how to become a...

An Easy Way to Beat the S&P 500
Blogs @ The Motley Fool - Motley Fool - Tue Jun 25, 1:10PM CDT
Beating the market isn't easy, but one very simple strategy outperforms year after year. It has nothing to do with market timing or leverage, nor do investors need to actively hunt down stocks. Most funds are market-cap weighted, so...

SmarTrend Watching for Potential Rebound in Shares of Rydex S&P Equal Weight ETF After 1.46% Loss
Comtex SmarTrend(R) - Wed Jun 05, 4:42PM CDT
Rydex S&P Equal Weight ETF (AMEX:RSP) traded in a range yesterday that spanned from a low of $61.13 to a high of $62.01. Yesterday, the shares fell 1.5%, which took the trading range below the 3-day low of $61.74 on volume of 3.4 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

Rydex S&P Equal Weight ETF Has Returned 20.7% Since SmarTrend Recommendation (RSP)
Comtex SmarTrend(R) - Fri May 31, 11:05AM CDT
SmarTrend identified an Uptrend for Rydex S&P Equal Weight ETF (AMEX:RSP) on November 29th, 2012 at $52.31. In approximately 6 months, Rydex S&P Equal Weight ETF has returned 20.73% as of today's recent price of $63.15.

Rydex S&P Equal Weight ETF Up 19.9% Since SmarTrend Uptrend Call (RSP)
Comtex SmarTrend(R) - Fri May 24, 9:57AM CDT
SmarTrend identified an Uptrend for Rydex S&P Equal Weight ETF (AMEX:RSP) on November 29th, 2012 at $52.31. In approximately 6 months, Rydex S&P Equal Weight ETF has returned 19.87% as of today's recent price of $62.70.

10 Year Report: Equal Weight Strategy Beats S&P 500
Ron DeLegge - ETFG - Thu Apr 25, 11:24PM CDT
Should investors start switching away from traditional market cap indexes?

Are Equal Weight ETFs Worth The Cost? - ETF News And Commentary
Zacks Equity Research - Zacks Investment Research - Wed Mar 20, 8:00AM CDT
Should investors pay a bit more for equal weighting, or is market capitalization the way to go?

S&P 500 ETFs: Comparing The “Twisted” Funds
Stoyan Bojinov - ETFDB - Thu Feb 28, 3:00AM CST
It’s pretty darn hard, if not altogether impossible, to read through any sort of financial publication these days without running across some mention of the S&P 500 Index. This revered benchmark has found its way onto the radar screens of...

Schwab Ups the Ante with Commission-Free ETF Platform
etf@etfguide.com - ETFG - Thu Feb 07, 11:29PM CST
Schwab will now include 105 ETFs from various families on its list of funds eligible for commission free trading.




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Stavian Group Eyes AI-Driven Southeast Asia Growth

Updated Category News Views 62

AI and Infrastructure: A New Chapter for Southeast Asia What does Southeast Asia's future look like with AI steering the ship? Well, there's a fresh breeze of change blowing, and right at the heart of it stands Stavian Group. At the recently held inaugural Fortune SEA500 Summit in Ho Chi Minh City, this conglomerate threw its hat into the ring, painting a vision of growth...

Continue Reading
ASTS Faces Class Action; Investors Beware of Pitfalls

Updated Category News Views 299

Securities Fraud Allegations Hit AST SpaceMobile Days like this remind me why we keep our eyes peeled in the stock game—AST SpaceMobile (NASDAQ: ASTS) is tangled in a web of legal drama, and it's something you can't brush off with a shrug. Class action lawsuits for securities fraud? That's like finding out the foundation's shaky beneath a skyscraper. If you've got skin...

Continue Reading
D-Wave's Legal Trouble: Securities Fraud Suit Looms

Updated Category News Views 351

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 343

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading
Cultural Tech Fusion: The Asia-Pacific Way Forward

Updated Category News Views 29

A High-Tech Twist on Traditional Culture You ever walk into a room and see a robot perform kung fu? I'll admit, it caught me off guard at first. But that's exactly what happened at the "Enduring Heritage, Harmonious Asia-Pacific" special exhibition in Shenzhen. With all the usual high-ranking execs and cultural bigwigs there, nobody expected a showcase where Wing Chun...

Continue Reading
FFR's OmniMind Takes Top Spot In RoboColiseum Rankings

Updated Category News Views 123

The AI Race Heats Up with FFR's Big Win Stop the presses—FFR's OmniMind AI just snagged the top spot on RoboColiseum's global rankings. Yeah, you heard right, this ain't just some run-of-the-mill news. As of November 6, they've parked themselves in pole position, beating out heavyweights like NVIDIA's GR00T N1.7 and GPT-6 Astra. That's like hitting a grand slam right...

Continue Reading
CureGene's Evategrel Aims for Breakthrough in Stroke Care

Updated Category News Views 69

Revolutionizing Stroke Care: Enter Evategrel When it comes to strokes, time is money—and I'm telling you, this ain't an area where you can afford to twiddle your thumbs. The faster you can get that blood flowing again, the better the chance you've got of walking away with less damage. That's where CureGene's new investigational drug, Evategrel, comes in. Why Evategrel...

Continue Reading
Webull Faces Class Action Suit: Key Deadlines Loom

Updated Category News Views 250

The Clock is Ticking for Webull Investors If anyone's got a Webull stake, listen up! You’ve got a deadline that's staring you in the face: December 7, 2026. This is when you need to throw your hat in the ring to be a lead plaintiff in the Webull Corporation class action. We're talking securities fraud, folks, with allegations flying that would make your head spin....

Continue Reading
Innovent's SINTBILO® Hits Primary Endpoint in Study

Updated Category News Views 119

Innovent's Latest Breakthrough with SINTBILO® One moment you're sipping coffee, the next you're staring at a clinical milestone. Innovent Biologics has shouted from the rooftops that their drug, SINTBILO® (tafolecimab injection), has wrapped up its Phase 3 CREDIT-5 study, snagging the primary endpoint with both hands. This isn't just any drug; it's marked as the first...

Continue Reading
Amplifon Data Breach Spurs Legal Scrutiny for Millions

Updated Category News Views 456

Data Breach Fallout: Amplifon Under Fire When a big player like Amplifon gets hit with a data breach, it's like a wake-up call across the board. This one’s no small spill—over 1.3 million folks left wondering whether their personal information is fluttering around cyberspace for all who dare to peek. If you’ve missed the memo, Edelson Lechtzin LLP, the savvy cats in...

Continue Reading

Top 5 Most Recently Viewed Articles

Brazil Potash Secures $75 Million Equity Line for Growth

Updated Category News Views 167

Brazil Potash Secures Key Funding for Autazes Project Brazil Potash Corp. (“Brazil Potash” or the “Company”) (NYSE American: GRO), a prominent player in mineral development focused on potash mining, has recently finalized a significant agreement establishing an equity line of credit (ELOC) with Alumni Capital LP. This collaboration signals a crucial step in...

Continue Reading
AGCO Completes Major Strategic Shift Transforming Business Focus

Updated Category News Views 101

AGCO Completes Divestiture of Grain & Protein Business AGCO Corporation (NYSE: AGCO), a leading firm in agricultural machinery and precision ag technology, has finalized the sale of the majority of its Grain & Protein business to American Industrial Partners (AIP) in an all-cash deal valued at around $700 million. This significant transition emphasizes AGCO's focus on...

Continue Reading
Vincent Bouatou Takes the Helm as CTO at IDEMIA Public Security

Updated Category News Views 64

Vincent Bouatou Appointed as Chief Technology Officer With a wealth of experience in the technology sector, Vincent Bouatou has been officially announced as the Chief Technology Officer (CTO) of IDEMIA Public Security. His extensive background in driving technological innovations positions him to make significant strides in the biometric technology industry. Driving...

Continue Reading
MedX Holdings, Inc. Reaches New Heights in Q1 Revenue Growth

Updated Category News Views 171

MedX Holdings, Inc. Reports Extraordinary Q1 Revenue Gains MedX Holdings, Inc. (OTC: MEDH) is delighted to share its impressive financial results for the first quarter of 2025. With record revenue levels and strategic advancements, this milestone reflects the company's commitment to becoming a prominent player in cannabis retail, technology, and franchise development....

Continue Reading
Erste Group Upgrades WW Grainger Stock Amid Positive Outlook

Updated Category News Views 74

Erste Group upgraded WW Grainger (NYSE: GWW) from Hold to Buy back in mid-2024, showing that the desks had a new favorite. With a return on equity at a whopping 59%, Grainger's performance left many competitors in the dust, making it a must-watch stock for anyone looking to get into industrial supply chains. What's Driving the Upgrade? The reasons behind this rating shift...

Continue Reading